News & Events
Combinostics Demonstrates Latest cNeuro® Features and Applications at RSNA 2021
Combinostics will demonstrate the features of cNeuro® 2.0, the latest release to their AI-based suite of products, and applications under development at RSNA 2021.
Arterys Partners with Combinostics to Accelerate Accurate and Consistent Evaluations of Patients with Neurodegenerative Disease and Multiple Sclerosis
Arterys has partnered with Combinostics to offer the most comprehensive neuro AI suite on the market, covering a broad set of applications in neuroradiology .
Combinostics Announces Addition of Greg Kingston as Chief Marketing Officer
Greg Kingston joins the Combinostics leadership team as Chief Marketing Officer (CMO). He has more than a decade of experience in the medical imaging software domain and a focus in AI-based technology.
RSNA 2021
Attending RSNA 2021? Stop by Booth #4937 in the AI Showcase and chat about cMRI, cDSI and more for automated MRI biomarker detection and quantification.
cNeuro 2.0
Combinostics today announced the release of cNeuro® cMRI 2.0 and cNeuro® cDSI 2.0.
Richard Hausmann Appointed as CEO of Combinostics
Richard Hausmann has been named Chief Executive Officer, effective June 1, 2021. Hausmann will succeed Lennart Thurfjell, who will transition to the role of Chief Operating Officer.
Horizon 2020 project on prevention of cognitive decline
Combinostics joined the EU funded Horizon 2020 project LETHE, a personalized prediction and intervention model for early detection and reduction of risk factors for dementia.
Young outstanding researcher award
Combinostics congratulates Hanneke Rhodius-Meester at Alzheimercentrum Amsterdam for her nomination for Alzheimer Nederland’s Young Outstanding Researcher (YOR) Award 2021.
Combinostics receives ISO27001 Information Security certification
ISO/IEC 27001:2013 is an ISMS standard and one of the most widely recognized certifications for information security controls and the identification and prevention of security risks.
